NEXZOL PHARMA
Dead / Cancelled — Cancelled — Section 8 (as of 21 Nov 2025)
What this means for you
This registration has been cancelled; it no longer blocks anyone on its own. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 87699430
- Registration number
- 5746594
- Mark type
- Stylized text
- Filed
- 28 Nov 2017
- Published for opposition
- 24 Apr 2018
- Registered
- 07 May 2019
- Attorney of record
- Sean MacKenzie
Goods and services
- Class 035 — Advertising and business services: Marketing services in the field of pharmaceuticals; Sales management services; Sales promotion services; Business research and data analysis services in the field of pharmaceutical distribution
- Class 042 — Scientific and technological services: Pharmaceutical research and development; Pharmaceutical research services
Owner
- Nexzol Pharma, Inc., San Clemente, CA, US
- Nexzol Pharma, Inc., San Clemente, CA, US
- NuRemedy Pharma LLC, Las Vegas, NV, US
- NuRemedy Pharma LLC, Las Vegas, NV, US
Prosecution history
- 21 Nov 2025 — CANCELLED SEC. 8 (6-YR)
- 07 May 2024 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 07 May 2019 — REGISTERED-PRINCIPAL REGISTER
- 03 Apr 2019 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 02 Apr 2019 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 27 Mar 2019 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 27 Mar 2019 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 21 Mar 2019 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 07 Jan 2019 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 17 Dec 2018 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 17 Dec 2018 — SOU TEAS EXTENSION RECEIVED
- 22 Sept 2018 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 22 Sept 2018 — NON-FINAL ACTION E-MAILED
- 22 Sept 2018 — SU - NON-FINAL ACTION - WRITTEN
- 20 Sept 2018 — STATEMENT OF USE PROCESSING COMPLETE